Independent register of U.S. FDA drug recalls · updated Oct 10, 2026
RxRecalls Get alerts
Class III · Low risk Terminated Initiated Apr 14, 2022 (4 years ago)

Phenobarbital Elixir

Class III — Low risk. Unlikely to cause harm, but violates FDA regulations.

Why it was recalled

Does Not Meet USP or OTC Monograph: Product exceeds USP specification for alcohol content

Cause type: Unapproved drug

The product was marketed without an approved NDA/ANDA, or does not meet the OTC monograph it claims to follow. Nothing about the product - dose, purity, safety - has been reviewed by FDA, so the claims on the box are unverified. All unapproved drug recalls.

What was recalled

Phenobarbital Elixir, USP 20 mg/5 mL, 1 Pint (473 mL) bottles, Rx Only, Manufactured for: Westminster Pharmaceuticals, LLC Tampa, FL 33624, NDC 69367-172-16

Affected NDC 69367-0172-16

Compare with the code on your package — it is the most precise check available.

Drug: Phenobarbital

Recalling firm
Monarch PCM, LLC
NDC code
69367-172-16
Origin
TX, United States
Initiated by
Voluntary: Firm initiated
FDA recall number
D-0878-2022 · FDA notice

Low risk, still worth a check. Class III means the product is unlikely to cause harm but breaks an FDA rule (often labeling). If your lot matches, your pharmacy will normally swap it; there is no need for alarm. This recall is now terminated, which means the firm has finished removing the affected product; anything on pharmacy shelves today should be unaffected.

Other Phenobarbital recalls

See all
Class II · Moderate risk

PHENOBARBITAL Sodium Injection

Lack of Assurance of Sterility: deviations from Current Good Manufacturing Practices (CGMP) that call into question the sterility of products intended to be sterile.

Terminated Sterility / contamination Vitae Enim Vitae Scientific, Inc. NDC 42494-416-25 D-0744-2022
Class II · Moderate risk

PHENOBARBITAL Sodium Injection

Lack of Assurance of Sterility: deviations from Current Good Manufacturing Practices (CGMP) that call into question the sterility of products intended to be sterile.

Terminated Sterility / contamination Vitae Enim Vitae Scientific, Inc. NDC 42494-415-25 D-0743-2022
Class II · Moderate risk

Phenobarbital Tablets

CGMP Deviations: Intermittent exposure to temperature excursion during storage.

Terminated Temperature excursion Cardinal Health Inc. NDC 13517-111-01 D-0470-2021
Class II · Moderate risk

Phenobarbital Oral Solution

cGMP Deviations: Potential product contamination with Burkholderia cepacia (B.cepacia) and Ralstonia pickettii (R. pickettii).

Terminated Microbial contamination Torrent Pharma Inc D-1365-2019
Class II · Moderate risk

Phenobarbital Oral Solution

Labeling: Incorrect or Missing Lot and/or Exp Date - the label contains an incorrect Exp Date.

Terminated Labeling / mix-up Lohxa LLC NDC 70166-536-02 D-1131-2019

Other recalls by Monarch PCM, LLC

All 2022 recalls
Class II · Moderate risk

Hydroquinone USP

Finished product specification did not meet USP specifications.

Terminated Other Monarch PCM, LLC NDC 69367-174-01 D-0855-2021
Class III · Low risk

Hydroquinone

Subpotency: one product for active ingredient assay and another one for preservative assay

Terminated Wrong potency / content Monarch PCM, LLC NDC 69367-174-01 D-0818-2021
Class III · Low risk

Sodium Sulfacetamide

Subpotency: one product for active ingredient assay and another one for preservative assay

Terminated Wrong potency / content Monarch PCM, LLC NDC 42808-103-06 D-0817-2021